Topic Teaching: NIPT in the Bud - Fetal RHD prediction for preventing and managing alloimmunization in pregnancy

Presented by:

Objectives:

1. Understand how cell free fetal DNA testing is used to predict fetal red cell antigen status
2. Recognize the role of non-invasive fetal RHD genotyping in 1) managing alloimmunized pregnancies and 2) targeted antenatal RhIG prophylaxis
3. Appreciate the advantages and challenges of implementing routine antenatal high throughput NIPT as part of a new paradigm of RhD alloimmunization prevention in Canada

References:

N/A

Note: The session is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada.

To register for the LearnTransfusion series, send an email to learn.transfusion@blood.ca with  “Weekly Transfusion Medicine Seminars” in the subject line. Include your name and complete e-mail address in the body of the e-mail, and confirm that you would like to register for the LearnTransfusion series. You will then receive weekly email notifications of upcoming series events with details on how to join the webinars (e.g., call-in number and a link to register for the webinar).

The LearnTransfusion series is the seminar component of the Areas of Focused Competency (AFC)-Diploma Program in Transfusion Medicine. The series, organized by Canadian Blood Services is also open to all practitioners in the field of Transfusion Medicine. Through a series of regular webinars, trainees and practitioners are exposed to various scientific, technical and clinical aspects of transfusion medicine.